- Publikationsjahr:
2018
- Titel:
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
- Autoren:
Welte, T.;Dellinger, R. P.;Ebelt, H.;Ferrer, M.;Opal, S. M.;Singer, M.;Vincent, J. L.;Werdan, K.;Martin-Loeches, I.;Almirall, J.;Artigas, A.;Ignacio Ayestarán, J.;Nuding, S.;Ferrer, R.;Sirgo Rodríguez, G.;Shankar-Hari, M.;Álvarez-Lerma, F.;Riessen, R.;Sirvent, J. M.;Kluge, S.;Zacharowski, K.;Bonastre Mora, J.;Lapp, H.;Wöbker, G.;Achtzehn, U.;Brealey, D.;Kempa, A.;Sánchez García, M.;Brederlau, J.;Kochanek, M.;Reschreiter, H. P.;Wise, M. P.;Belohradsky, B. H.;Bobenhausen, I.;Dälken, B.;Dubovy, P.;Langohr, P.;Mayer, M.;Schüttrumpf, J.;Wartenberg-Demand, A.;Wippermann, U.;Wolf, D.;Torres, A.
- Journal:
Intensive Care Med
- DOI:
10.1007/s00134-018-5143-7
